Company

Portal Biotech Limited

Portal Biotech develops nanopore instruments and services for single-molecule protein analysis.

About

Portal Biotech develops bench-top instruments using nanopore technology to characterize proteins and metabolites. Its products and services are aimed at academic institutions and biopharmaceutical companies. Founded in 2021, the company is based in London, UK. In June 2025, it raised USD 35.00 mn in Series A funding, including investment from NATO Innovation Fund and Earlybird Venture Capital.

1Funding rounds

10Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in